Given the proposed roles of TSP1 in insulin resistance and low-grade chronic inflammation [5,6], this molecule may represent a promising target for both pharmacological and lifestyle interventions (i.e., exercise and caloric restriction). The gene discussed is THBS1; the disease is Insulin resistance.